Michael E. Mullendore

4.9k total citations · 2 hit papers
21 papers, 3.7k citations indexed

About

Michael E. Mullendore is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michael E. Mullendore has authored 21 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Michael E. Mullendore's work include Hedgehog Signaling Pathway Studies (5 papers), MicroRNA in disease regulation (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Michael E. Mullendore is often cited by papers focused on Hedgehog Signaling Pathway Studies (5 papers), MicroRNA in disease regulation (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Michael E. Mullendore collaborates with scholars based in United States, Netherlands and Germany. Michael E. Mullendore's co-authors include Anirban Maitra, Georg Feldmann, Joshua T. Mendell, Oliver A. Kent, Erik A. Wentzel, Dan E. Arking, Munekazu Yamakuchi, M Beer, Tsung-Cheng Chang and Marcella Ferlito and has published in prestigious journals such as Genes & Development, Molecular Cell and Cancer Research.

In The Last Decade

Michael E. Mullendore

21 papers receiving 3.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis

2007 1.6k citations Tsung-Cheng Chang, Erik A. Wentzel et al. Molecular Cell profile →
Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers

2007 537 citations Georg Feldmann, Surajit Dhara et al. Cancer Research profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael E. Mullendore	2.9k	2.0k	1.2k	239	193	21	3.7k
Shu‐Chun Lin	2.6k 0.9×	1.9k 1.0×	892 0.8×	156 0.7×	187 1.0×	71	3.7k
Naohiro Nishida	2.6k 0.9×	2.2k 1.1×	776 0.7×	247 1.0×	147 0.8×	72	3.6k
Ulrike Burk	2.7k 0.9×	1.9k 1.0×	1.4k 1.2×	236 1.0×	196 1.0×	14	3.6k
Arti Gaur	2.8k 1.0×	2.4k 1.2×	717 0.6×	171 0.7×	243 1.3×	28	3.8k
Mingxia Yan	1.9k 0.6×	1.4k 0.7×	945 0.8×	141 0.6×	152 0.8×	37	2.7k
Eva Bandrés	3.5k 1.2×	2.9k 1.4×	843 0.7×	178 0.7×	381 2.0×	78	4.9k
Peixin Dong	2.4k 0.8×	1.8k 0.9×	942 0.8×	132 0.6×	366 1.9×	72	3.4k
Xinhua Xie	2.1k 0.7×	1.8k 0.9×	870 0.7×	188 0.8×	229 1.2×	76	3.1k
Fengyan Yu	3.0k 1.0×	2.4k 1.2×	1.3k 1.1×	132 0.6×	535 2.8×	44	4.1k
Oliver A. Kent	3.5k 1.2×	3.0k 1.5×	484 0.4×	127 0.5×	207 1.1×	32	4.2k

Countries citing papers authored by Michael E. Mullendore

Since Specialization

Citations

This map shows the geographic impact of Michael E. Mullendore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Mullendore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Mullendore more than expected).

Fields of papers citing papers by Michael E. Mullendore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Mullendore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Mullendore. The network helps show where Michael E. Mullendore may publish in the future.

Co-authorship network of co-authors of Michael E. Mullendore

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Mullendore. A scholar is included among the top collaborators of Michael E. Mullendore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Mullendore. Michael E. Mullendore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Touny, Lara H. El, Curtis Hose, John Connelly, et al.. (2021). ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide. Oncotarget. 12(21). 2114–2130. 8 indexed citations

Hollingshead, Melinda G., Luke H. Stockwin, Sergio Y. Alcoser, et al.. (2014). Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages - strategies for data mining in support of therapeutic studies. BMC Genomics. 15(1). 393–393. 26 indexed citations

Mullendore, Michael E., et al.. (2013). Oxyphenisatin acetate (NSC59687) triggers a cell starvation response leading to autophagy, mitochondrial dysfunction, and autocrineTNFα‐mediated apoptosis. Cancer Medicine. 2(5). 687–700. 12 indexed citations

Glaros, Trevor, et al.. (2012). The “survivin suppressants” NSC 80467 and YM155 induce a DNA damage response. Cancer Chemotherapy and Pharmacology. 70(1). 207–212. 83 indexed citations

Newton, Dianne L., Luke H. Stockwin, Michael E. Mullendore, et al.. (2012). Abstract 2810: NSC 743380 induces apoptosis in sensitive cell lines through activation of tyrosine kinase 2 (Tyk2). Cancer Research. 72(8_Supplement). 2810–2810. 1 indexed citations

Kent, Oliver A., Raghu R. Chivukula, Michael E. Mullendore, et al.. (2010). Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes & Development. 24(24). 2754–2759. 255 indexed citations

Mullendore, Michael E., Yue‐Ming Li, G. J. A. Offerhaus, et al.. (2009). Ligand-dependent Notch Signaling Is Involved in Tumor Initiation and Tumor Maintenance in Pancreatic Cancer. Clinical Cancer Research. 15(7). 2291–2301. 150 indexed citations

Kent, Oliver A., Michael E. Mullendore, Pedro López‐Romero, et al.. (2009). A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells. Cancer Biology & Therapy. 8(21). 2013–2024. 95 indexed citations

Habbe, Nils, Joshua T. Mendell, G. Johan A. Offerhaus, et al.. (2009). MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biology & Therapy. 8(4). 340–346. 243 indexed citations

10.

Álvarez, Héctor M., Alejandro H. Corvalán, Juan Carlos Roa, et al.. (2008). Serial Analysis of Gene Expression Identifies Connective Tissue Growth Factor Expression as a Prognostic Biomarker in Gallbladder Cancer. Clinical Cancer Research. 14(9). 2631–2638. 33 indexed citations

11.

Feldmann, Georg, Nils Habbe, Savita Bisht, et al.. (2008). Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut. 57(10). 1420–1430. 146 indexed citations

12.

Habbe, Nils, Jeanne Mendell, G. Johan A. Offerhaus, et al.. (2008). MICRORNA MIR-155 IS A BIOMARKER OF EARLY PANCREATIC NEOPLASIA. Pancreas. 37(4). 473–473. 15 indexed citations

13.

Bisht, Savita, Georg Feldmann, Michael E. Mullendore, et al.. (2008). In vivocharacterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities. Molecular Cancer Therapeutics. 7(12). 3878–3888. 50 indexed citations

14.

Feldmann, Georg, Surajit Dhara, Volker Fendrich, et al.. (2007). Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers. Cancer Research. 67(5). 2187–2196. 537 indexed citations breakdown →

15.

Chang, Tsung-Cheng, Erik A. Wentzel, Oliver A. Kent, et al.. (2007). Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis. Molecular Cell. 26(5). 745–752. 1627 indexed citations breakdown →

16.

Fendrich, Volker, Jens Waldmann, Farzad Esni, et al.. (2007). Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum. Endocrine Related Cancer. 14(3). 865–874. 59 indexed citations

17.

Habbe, Nils, et al.. (2006). Mitochondrial DNA Mutations in Pancreatic Cancer. International Journal of Gastrointestinal Cancer. 37(2-3). 57–64. 29 indexed citations

18.

Karikari, Collins, Michael E. Mullendore, James R. Eshleman, et al.. (2005). Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers. Molecular Cancer Therapeutics. 4(12). 1860–1866. 30 indexed citations

19.

Mullendore, Michael E., et al.. (2002). Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy. BMC Physiology. 2(1). 1–1. 49 indexed citations

20.

Ward, Donald E., Christopher J. Donnelly, Michael E. Mullendore, et al.. (2001). The NADH oxidase from Pyrococcus furiosus. European Journal of Biochemistry. 268(22). 5816–5823. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact